Buy Agencium

Revolutionary approach for early detection of cancer using volatile organic compounds (VOCs) as biomarkers

Translating VOC research
into clinical applications

We are a healthtech company transforming the huge potential of VOCs biomarkers into clinical applications for early cancer detection and precision medicine.

We are currently developing our wide multi-screening platform that covers the early detection of a broad range of cancer types, reducing cancer-associated mortality worldwide.

0 M

people die every year
from cancer

0 M

lives can be saved yearly
with early cancer detection

Our value proposition|

Our values

Highly accurate
Non-invasive
Fast for sampling, detection and analysis
Not harmful to healthy cells

Every cancer has a VOC signature called scent.

A cancer scent can be detected at a very early stage, before tumor growth.

How it works

Volatile organic compounds VOCs are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions. They are by-products of the metabolic processes within the body and form the “odorprint” of an individual.

Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.

This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer. As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.

Your odorprint is a powerful tool that reflects your health status

Volatile organic compounds VOCs are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions. They are by-products of the metabolic processes within the body and form the “odorprint” of an individual.

Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.

This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer. As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.

Your odorprint is a powerful tool that reflects your health status

Volatile organic compounds VOCs are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions. They are by-products of the metabolic processes within the body and form the “odorprint” of an individual.

Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.

This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer.

As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.

Team

Founders

Riad-final
Founder / Head of R&D
Riad Sarkis, MD, PhD
Sarah
Co-Founder / CEO
Sarah Haddad, PhD
Kai
Co-Founder / Executive Chairman
Kai Karttunen

Our Service
will start soon!

Contact us

Get in touch

Vocoma AG
Oberneuhofstrasse 10,
6340 Baar, Switzerland

© Vocoma AG 2024. All rights reserved.

Send a message
Please enable JavaScript in your browser to complete this form.

© Vocoma AG 2024. All rights reserved.

We recycle body waste for accurate early cancer detection